Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
WDNAvsIBBETF Comparison
WisdomTree BioRevolution Fund (WDNA) belongs to the BioTech & Genomics segment. iShares Biotechnology ETF (IBB) is part of the US Health Care segment. WDNA's top 3 sector exposures are Health Care, Materials and Consumer Staples. In contrast, IBB's top sector exposures are Health Care, WDNA is more expensive with a Total Expense Ratio (TER) of 0.45%, versus 0.44% for IBB. WDNA is up 4.96% year-to-date (YTD) with -$357K in YTD flows. IBB performs worse with 1.32% YTD performance, and -$114M in YTD flows. Run a side-by-side ETF comparison of WDNA and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
WDNA vs IBB performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | WDNA IBB | -0.46%-1.01% | +4.60%+0.56% | +4.96%+1.32% | +38.09%+27.96% | +12.49%+37.52% | n/a+11.22% |
| Flows | WDNA IBB | -$357K+$211M | -$357K-$360M | -$357K-$114M | -$357K+$659M | -$524K-$1.65B | --$2.40B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | WDNA IBB | +22.81%+20.19% | +28.57%+23.43% | +24.57%+19.45% | n/a+22.09% |
| Max drawdown | WDNA IBB | -8.60%-5.59% | -17.47%-17.66% | -37.80%-24.82% | n/a-39.75% |
| Max drawdown duration | WDNA IBB | 48d48d | 106d148d | 901d377d | n/a1611d |
WDNA | IBB | |
Last sale 3/12/2026 at 1:30 PM | $17.25 | $166.23 |
| Previous close 03/11/2026 | $17.67 | $170.87 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
WDNA | IBB | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
WDNA | IBB | |
|---|---|---|
| Last price | $17.25 | $166.23 |
| 1D performance | -2.35% | -2.72% |
| AuM | $2.31 M | $8.34 B |
| E/R | 0.45% | 0.44% |
WDNA | IBB | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | WisdomTree | iShares |
| Benchmark | WisdomTree BioRevolution Index | ICE Biotechnology Index |
| N° of holdings | 75 | 182 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 3, 2021 | February 5, 2001 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the WDNA and IBB ETFs performed in 2026?
As of March 11, 2026, WDNA is up 4.96% year-to-date (YTD), while IBB has returned 1.32%. That puts WDNA better performer ahead so far this year.
Which ETF is attracting more investor money: WDNA or IBB?
Year-to-date, the WDNA ETF saw -$357K in flows, compared to -$114M for IBB.
Which ETF is more volatile: WDNA or IBB?
Over the past year, WDNA had a volatility of 28.57%, while IBB experienced 23.43%.
Which ETF is bigger: WDNA or IBB?
As of March 11, 2026, WDNA holds $2.31 M in assets under management (AUM), while IBB manages $8.34 B.
What sectors do the WDNA and IBB ETFs invest in?
WDNA leans toward sectors like Health Care. Meanwhile, IBB focuses on Health Care.
What are the top holdings of the WDNA ETF and IBB ETF?
WDNA top holdings include US86366E1064, MODERNA INC and NATERA. IBB holds in its top three: GILEAD SCIENCES, VERTEX PHARMACEUTICALS and AMGEN-T.
Which ETF is more diversified: WDNA or IBB?
WDNA holds 85 securities with 37.91% of its assets in the top 15. IBB has 254 securities and a top 15 weight of 56.67%.
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
Are Biotechnology ETFs In the Midst of a Comeback?
Investing in the Aging Population: A Look at Bonds and Pharma ETFs
Health is Wealth: A look at the Healthcare Sector
Biotech ETFs – Investing in Health Innovation
Biotech ETFs – Investing in Health Innovation
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
